Cargando…

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

Translocations involving the immunoglobulin heavy chain (IGH) locus are common abnormalities in B-lymphoblastic leukemia/lymphoma (B-ALL) and multiple myeloma. These rearrangements result in a juxtaposition of IGH enhancers to the vicinity of oncogenes, such as MYC and CRLF2, leading to the upregula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Yanglan, Wang, Man, Hu, Shuhong, Wang, Tanzhen, Liu, Yujie, Xiao, Jinyan, Cai, Yiming, Wang, Ying, Qiu, Huiying, Tang, Xiaowen, Chen, Suning, Wu, Depei, Xu, Yang, Liu, Tianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330356/ https://www.ncbi.nlm.nih.gov/pubmed/35912172 http://dx.doi.org/10.3389/fonc.2022.896858

Ejemplares similares

Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia
por: Tian, Liqing, et al.
Publicado: (2019)

FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML
por: Zhang, Jubin, et al.
Publicado: (2022)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
por: Yasumi, Masato, et al.
Publicado: (2020)

Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing
por: Wu, Jinghua, et al.
Publicado: (2016)

“Double hit” B-lymphoblastic lymphoma with concurrent IGH/BCL2 and 8q24/MYC translocations: a case report
por: He, Lu, et al.
Publicado: (2021)

Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements
por: Huh, Jungwon, et al.
Publicado: (2015)

IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile
por: Li, Qinlu, et al.
Publicado: (2022)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Long-range Oncogenic Activation of IgH/c-myc Translocations by the IgH 3’ Regulatory Region
por: Gostissa, Monica, et al.
Publicado: (2009)

Extranodal marginal zone lymphoma of the dura mater with IgH/MALT1 translocation and review of literature
por: Bhagavathi, Sharathkumar, et al.
Publicado: (2008)

The complex translocation (9;14;14) involving IGH and CEBPE genes suggests a new subgroup in B-lineage acute lymphoblastic leukemia
por: Zerrouki, Rachid, et al.
Publicado: (2016)

Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
por: Alpatov, Roman, et al.
Publicado: (2015)

CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
por: Yao, Zhenzhen, et al.
Publicado: (2023)

Genomic Architecture may Influence Recurrent Chromosomal Translocation Frequency in the Igh Locus
por: Kenter, Amy L., et al.
Publicado: (2013)

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics
por: Hoang, Phuc H., et al.
Publicado: (2020)

Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature
por: Li, Xuewei, et al.
Publicado: (2021)

Structural basis of DUX4/IGH-driven transactivation
por: Dong, Xue, et al.
Publicado: (2018)

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia
por: Sampathi, Shilpa, et al.
Publicado: (2022)

Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma
por: Tsukamoto, Taku, et al.
Publicado: (2023)

Molecular Evaluation of t(14;18)(bcl-2/IgH) Translocation in Follicular Lymphoma at Diagnosis Using Paraffin-Embedded Tissue Sections
por: Selvi, Nur, et al.
Publicado: (2012)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022)

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia
por: Vesely, C, et al.
Publicado: (2017)

t(9;14)(p13;q32)/ PAX5 -IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma
por: Ohno, Hitoshi, et al.
Publicado: (2021)

Identification of RyR2-PBmice and the effects of transposon insertional mutagenesis of the RyR2 gene on cardiac function in mice
por: Wang, Qianqian, et al.
Publicado: (2019)

IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients
por: He, Jian, et al.
Publicado: (2011)

Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
por: Chen, Suning, et al.
Publicado: (2022)

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients
por: Thomson, Ashlee J., et al.
Publicado: (2023)

CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation
por: Li, Shijia, et al.
Publicado: (2023)

Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
por: Zhang, Keyuan, et al.
Publicado: (2023)

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
por: Liu, Sining, et al.
Publicado: (2023)

The t(11;14)(q13;q32)/CCND1–IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course
por: Liu, Ying, et al.
Publicado: (2019)

Translocation junctions in TCF3-PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements
por: Rodić, Nemanja, et al.
Publicado: (2013)

A Novel IL3-ETV6 Fusion in Chronic Eosinophilic Leukemia Not Otherwise Specified With t(5; 12) (q31; p13): A Case Report and Literature Review
por: Zhao, Cenzhu, et al.
Publicado: (2022)

Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma
por: Yan, J, et al.
Publicado: (2014)

IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication
por: Wu, Xuemei, et al.
Publicado: (2023)

Genomic landscape of T-cell lymphoblastic lymphoma
por: Li, Zhaoming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m186o3cbnip5s6gjs28icmv8ei